Literature DB >> 21629239

The role of fecal elastase-1 in detecting exocrine pancreatic disease.

John S Leeds1, Kofi Oppong, David S Sanders.   

Abstract

Exocrine pancreatic disease is thought to be uncommon in clinical practice and usually secondary to excess alcohol intake. Although excess alcohol intake does account for many cases of exocrine pancreatic disease, other conditions are associated with exocrine pancreatic insufficiency and such dysfunction perhaps occurs more frequently than conventionally expected. A reliable, patient-friendly, cheap and easy to use test for exocrine pancreatic disease is yet to be established; however, in many countries the main (and often only available) method of assessment of exocrine pancreatic function is the fecal-elastase-1 test. This Review examines the role of fecal-elastase-1 testing in detecting exocrine pancreatic insufficiency in a number of gastrointestinal and nongastrointestinal conditions and determines the value of pancreatic enzyme supplementation in these settings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21629239     DOI: 10.1038/nrgastro.2011.91

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  125 in total

1.  The pathologic effects of large amounts of glucagon.

Authors:  J M SALTER; I W DAVIDSON; C H BEST
Journal:  Diabetes       Date:  1957 May-Jun       Impact factor: 9.461

2.  Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea.

Authors:  B Fischer; S Hoh; M Wehler; E G Hahn; H T Schneider
Journal:  Scand J Gastroenterol       Date:  2001-07       Impact factor: 2.423

3.  Influence of jejunal morphology changes on exocrine pancreatic function in celiac disease.

Authors:  S Nousia-Arvanitakis; T Karagiozoglou-Lamboudes; C Aggouridaki; E Malaka-Lambrellis; A Galli-Tsinopoulou; M Xefteri
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-07       Impact factor: 2.839

4.  Exocrine pancreatic function in chronic liver diseases.

Authors:  T Hayakawa; T Kondo; T Shibata; M Kitagawa; Y Sakai; H Sobajima; H Ishiguro; Y Nakae; K Kato
Journal:  Am J Gastroenterol       Date:  1991-02       Impact factor: 10.864

Review 5.  Diagnosis of chronic pancreatitis: Functional testing.

Authors:  J Enrique Domínguez Muñoz
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-06       Impact factor: 3.043

6.  Ultrasonographic abnormalities of the pancreas in IDDM and NIDDM patients.

Authors:  M E Silva; D P Vezozzo; M J Ursich; D M Rocha; G G Cerri; B L Wajchenberg
Journal:  Diabetes Care       Date:  1993-09       Impact factor: 19.112

7.  Treatment failure in celiac disease due to coexistent exocrine pancreatic insufficiency.

Authors:  Z Weizman; J R Hamilton; H R Kopelman; G Cleghorn; P R Durie
Journal:  Pediatrics       Date:  1987-12       Impact factor: 7.124

8.  Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis.

Authors:  Philip D Hardt; Axel M Marzeion; Henning Schnell-Kretschmer; Oliver Wüsten; Jens Nalop; Tobias Zekorn; Hans U Klör
Journal:  Pancreas       Date:  2002-07       Impact factor: 3.327

9.  A study of pancreatic function among subjects over ninety years of age.

Authors:  Lucio Gullo; Patrizia Simoni; Marina Migliori; Laura Lucrezio; Michela Bassi; Franca Frau; Pier Lorenzo Costa; Vincenzo Nesticò
Journal:  Pancreatology       Date:  2009-04-29       Impact factor: 3.996

10.  Determinants of Exocrine Pancreatic Function as Measured by Fecal Elastase-1 Concentrations (FEC) in Patients with Diabetes mellitus.

Authors:  Nils Ewald; A Raspe; C Kaufmann; R G Bretzel; H U Kloer; P D Hardt
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175

View more
  30 in total

1.  Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates.

Authors:  Gregor Fuhrmann; Andrea Grotzky; Ružica Lukić; Simon Matoori; Paola Luciani; Hao Yu; Baozhong Zhang; Peter Walde; A Dieter Schlüter; Marc A Gauthier; Jean-Christophe Leroux
Journal:  Nat Chem       Date:  2013-06-09       Impact factor: 24.427

Review 2.  Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.

Authors:  Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2013-11-02       Impact factor: 4.200

Review 3.  [Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Sandra Zlamal-Fortunat; Heinz F Hammer
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

4.  How to manage: patient with a low faecal elastase.

Authors:  Kwan Wai Lam; John Leeds
Journal:  Frontline Gastroenterol       Date:  2019-11-15

Review 5.  Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.

Authors:  J Enrique Domínguez-Muñoz; Philip D Hardt; Markus M Lerch; Matthias J Löhr
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

6.  Detection of human elastase isoforms by the ScheBo Pancreatic Elastase 1 Test.

Authors:  Anna Zsófia Tóth; András Szabó; Eszter Hegyi; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-03-30       Impact factor: 4.052

7.  Diagnosis of Exocrine Pancreatic Insufficiency.

Authors:  Phil A Hart; Darwin L Conwell
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 8.  Structure and function of the exocrine pancreas in patients with type 1 diabetes.

Authors:  Laure Alexandre-Heymann; Roberto Mallone; Christian Boitard; Raphaël Scharfmann; Etienne Larger
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 9.  Diagnosis and treatment of pancreatic exocrine insufficiency.

Authors:  Björn Lindkvist
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

10.  [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Werner Fortunat; Heinz Hammer
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.